Clinical trial
Butrans for Treatment of Restless Legs Syndrome
NCT02138357 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Butrans for Treatment of Restless Legs Syndrome
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- April 30, 2014
- Completion date
- December 31, 2016
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.